Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/2005
11/24/2005US20050260715 Efficient methods for producing antimicrobial cationic peptides in host cells
11/24/2005US20050260685 Arrays of biological membranes and methods and use thereof
11/24/2005US20050260674 Specific polypeptides, useful as nematocides
11/24/2005US20050260673 nematode-specific gene products that can serve as targets for inhibitory peptides and proteins (e.g., antibodies) and antiparasitic chemicals
11/24/2005US20050260672 Methods of tangential flow filtration and an apparatus therefore
11/24/2005US20050260653 Nucleic-acid programmable protein arrays
11/24/2005US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/24/2005US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/24/2005US20050260600 Amino radicals; magnetic bodies, metals, plastic and glass beads or gel; increased recovery ratio
11/24/2005US20050260154 G-CSF analog compositions and methods
11/24/2005US20050258097 Method and device for extracting an analyte
11/24/2005CA2567109A1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities
11/24/2005CA2564126A1 Method of inducing immunity against stratum corneum chymotrytic enzyme
11/24/2005CA2560981A1 Polymer-based sustained release device
11/23/2005EP1598365A1 Protection of endogenous therapeutic peptides
11/23/2005EP1598075A1 Process for the isolation and / or purification of proteins
11/23/2005EP1597585A2 Method for selecting a candidate drug compound
11/23/2005EP1597383A2 Variants of cytochrome c and methods of diagnosis of thrombocytopenia
11/23/2005EP1597348A2 Conserved and specific streptococcal genomes
11/23/2005EP1597278A2 Polyethylene glycol modified interferon compositions and methods of use thereof
11/23/2005EP1596667A2 Process for concentration of macromolecules
11/23/2005EP1341932A4 Improved methods for gene expression monitoring on electronic microarrays
11/23/2005EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition
11/23/2005EP0892810B1 Crystallization of a protein with a sulphur salt
11/23/2005CN1699407A Process for separating and purifying polypeptide prepared by chemical synthesis
11/23/2005CN1699406A Method for gel electrophoresis separation of serum lipoprotein and quantization detection thereof
11/23/2005CN1699405A Process for preparing low-molecular insect protein by pressure hydrolysis of fly maggot protein
11/23/2005CN1699404A Process for solid-phase microwave synthesis of polypeptide
11/23/2005CN1228450C Antigenic preparations
11/23/2005CN1228345C Insoluble silk fibroin film and preparation of silk fibroin pipe
11/22/2005US6967241 Process for protein extraction
11/22/2005US6967240 proteinaceous compound or functionally active derivative thereof having a binding site for a group of toxins derived from various cyanobacteria, to a method for its production, diagnostic kits, and affinty matrix for use in immunoaffinity column
11/22/2005US6967239 obtaining a starting factor VIII solution comprising factor VIII-von Willebrand factor complexes; and filtering in presence of calcium chloride ions through hydrophilic virus filter having a mean pore size of 13 to 17 nm
11/22/2005US6966992 Purification of preferential particle from sample; obtain sample mixture, expose to chromatographic column, elute particle from column, recover particle
11/22/2005CA2251558C Highly purified factor viii complex
11/17/2005WO2005109158A2 Methods and systems for generating peptides
11/17/2005WO2005108615A2 Nucleic-acid programmable protein arrays
11/17/2005WO2005108567A1 Method of constructing modified protein
11/17/2005WO2005107491A2 Multi-lectin affinity chromatography and uses thereof
11/17/2005WO2005092923A3 Cytonectin and gene inhibitors thereof
11/17/2005WO2005062725A3 Method for enrichment/separation of protein or peptide
11/17/2005WO2004083405A8 Separation and accumulation of subcellular components, and proteins derived therefrom
11/17/2005WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/17/2005WO2004005318A3 Peptides comprising aromatic d-amino acids and methods of use
11/17/2005US20050256300 Method for using a static electric field to induce crystallization and to control crystal form
11/17/2005US20050256298 Method for preparing free flow resin
11/17/2005US20050256049 Chimeric toxins for targeted therapy
11/17/2005US20050256030 Heterocyclic self-immolative linkers and conjugates
11/17/2005US20050255556 Refolding of ion channel proteins
11/17/2005US20050255526 Anti-tag antibody chip for protein interaction analysis
11/17/2005US20050255227 Flat regenerated cellulose or polyether sulfone membranes of substantially the same molecular weightare stacked together; by employing membranes in series without any gaskets or spacers in-between, ultrafiltration is carried out to separate two proteins relatively close in molecular weight or size
11/17/2005US20050255138 Active agent transport systems
11/17/2005CA2566195A1 Process for the preparation of doxorubicin conjugates with lactosaminated human albumin and the obtained conjugates
11/17/2005CA2565731A1 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification
11/17/2005CA2563168A1 Nucleic-acid programmable protein arrays
11/16/2005EP1596196A2 Protein interaction chip
11/16/2005EP1595889A1 Method of eliminating phosphate group of peptide and method of analyzing peptide
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide
11/16/2005EP1594442A2 Knockout identification of target-specific sites in peptides
11/16/2005EP1594433A2 Cancer therapy sensitizer
11/16/2005EP1324975B1 Dynamic resolution of isomers and resolved isomers
11/16/2005EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia
11/16/2005EP0477295B2 Platelet aggregation inhibitors
11/16/2005CN1697839A Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
11/16/2005CN1697792A Improved extraction process
11/16/2005CN1696700A Anti-tag antibody chip for protein interaction analysis
11/16/2005CN1696150A Self-balanced connected device for collecting separated liquid in use for electrophoresis of free stream
11/16/2005CN1696149A Buffered split flow device in use for electrophoresis of free stream
11/16/2005CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them
11/16/2005CN1227261C Monocyclic compounds with four bifunctional residues having NK-2 antagonist action, its preparation, medicine compositions and uses
11/16/2005CN1227025C Improved methods for processing activated protein C
11/15/2005US6965014 Bioerodible film; mixture of thrombin and fibrinogen; controlling coagulation; drug delivery of antitumor, anticancer agents
11/15/2005US6964735 Supporting medium with an organic polymer substrate having a substantially uncharged surface
11/15/2005CA2302360C Fluorination of proteins and peptides for f-18 positron emission tomography
11/10/2005WO2005106447A1 Method for detection and analysis of macromolecular complexes
11/10/2005WO2005105994A1 Method of disulfide crosslink forming type in vitro protein synthesis
11/10/2005WO2005089503A3 Cd4-igg2 formulations
11/10/2005WO2005084210A3 Multiplex detection probes
11/10/2005WO2005073711A3 Chromatographic material for the absorption of proteins at physiological ionic strength
11/10/2005WO2005063791B1 Process for peptide synthesis using a reduced amount of deprotection agent
11/10/2005WO2005014779A3 Cyclodextrin affinity purification
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050250693 Metalloproteinase inhibitors
11/10/2005US20050250678 polypeptide (interferon, colony stimulating factor, human growth hormone) having an O-linked glycosylation site that does not exist in a wild type polypeptide; glycoconjugates in which a species such as a water-soluble polymer, a therapeutic agent or a biomolecule is covalently linked through the site
11/10/2005US20050250136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/10/2005US20050249828 Canola protein isolate compositions
11/10/2005CA2564831A1 Method of forming disulfide crosslink in in vitro protein synthesis
11/09/2005EP1593686A1 Antineoplastic peptides
11/09/2005EP1592703A1 Method for protein isolation in anoxic conditions
11/09/2005EP1592476A1 Methods for the purification of stable radioiodine conjugates
11/09/2005EP1592440A2 Immunoglobulin formulation and method of preparation thereof
11/09/2005EP1551878A4 Method of inactivating prions
11/09/2005EP1349829A4 Catalyst modification to enhance neotame production
11/09/2005EP1165782B1 Improved methods for recombinant peptide production
11/09/2005EP0808330B1 A process for preparing certain aza cyclohexapeptides
11/09/2005CN1226305C Protein extracted from perinereis aibuhitensis, its preparation method and use
11/08/2005US6962975 from transgenic mouse brains, for infection of humans, cows, and sheep; for bioassay
11/08/2005US6962972 Active material; denaturing protein; hybrid enzyme
11/08/2005US6962934 Such as N-((2S)-2-((3-((dipropylamino)carbonyl)-benzoyl) amino)-3-phenylpropyl)-L-alanyl-N1-isobutyl-L-valinamide; secretase inhibitors
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 518